Roto-Gro Hit with Counterclaim in Patent Infringement Dispute

Roto-Gro Hit with Counterclaim in Patent Infringement Dispute

A case of patent infringement between an Australian company and a Canadian cannabis firm is heating up with confirmation of a response and a counterclaim.

A Canadian cannabis company is firing back at RotoGro International (ASX:RGI) with a statement of defence in the midst of a growing battle over a gardening patent infringement.

On Wednesday (December 18), RavenQuest BioMed (CSE:RQB,OTCQB:RVVQF) confirmed that it has served RotoGro with a statement of defence and counterclaim, which has been filed with the Federal Court of Canada.

RotoGro first filed a statement of patent infringement for its modular orbital gardening system against RavenQuest and other parties last month. Now, the Canadian player maintains it developed the intellectual property around the gardening system and it’s defending its right to use the machinery.

“The company strenuously denies any infringement of Roto-Gro Inc.’s alleged patent rights and has counterclaimed against Roto-Gro Inc. seeking, among other things, a declaration of invalidity of the recent patent upon which Roto-Gro, Inc. relies,” RavenQuest said in a statement.

The firm is also looking for RotoGro to cover the cost of its claims on a full indemnity basis.

The dispute between the two companies goes back to November when RotoGro filed a statement of patent infringement for its modular gardening system against RavenQuest, also naming CL2G Consulting, Synergy Solutions Management, 1052543 B.C. and William George Robinson, RavenQuest’s CEO himself.

RotoGro first received the patent for the system from the Canadian Intellectual Property Office in October, giving it exclusive rights construction and sale rights.

Adam Clode, CEO of RotoGro, previously said it was important for the company to protect its gardening system in the US and Canada since it is integral to its business plans. “We owe this duty to our shareholders, and to the company as a whole,” Clode said.

The patent in question protects “a stacked rotatable gardening system comprising numerous modular rotatable gardens being stacked vertically (i.e., one on top of the other) and horizontally (i.e., side by side), where each main frame is connected to the main frame of the other modular rotatable garden, forming system pods.”

RotoGro claims Robinson purchased two gardening systems in 2016 while operating as the sole proprietor of CL2G Consulting. At the end of 2017, Robinson began negotiations with RotoGro to obtain a licensing deal for the system, but no agreement was ever finalized.

According to the Australian firm, RavenQuest published a promotional paper using a drawing identical to RotoGro’s patented gardening system, prompting RotoGro to send the first of two cease and desist letters to RavenQuest and Robinson.

The second letter tagged RavenQuest for using the term “orbital gardens” in an advertisement, which infringes on RotoGro’s patent rights.

Following the claim, RavenQuest responded with its own statement in November, saying the claim was baseless.

RavenQuest shares have been down 8.3 percent since the beginning of the trading week and opened at C$0.11 on Wednesday.

RotoGro started the trading day at AU$0.14 before dropping to AU$0.13 near market close.

Don’t forget to follow us @INN_Australia for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

When Will Australia Legalise Recreational Cannabis?

Recreational cannabis remains illegal in all Australia’s states and territories with the exception of the Australian Capital Territory (ACT). But could that change in the future?

So far there are no clear indicators as to when or if Australia could legalise recreational cannabis, but attitudes seem to be changing. Public support is growing, and there’s even some political acceptance.

Read on to learn more about when Australia may legalise recreational cannabis.

Keep reading... Show less

A State-by-State Guide to Cannabis in Australia

Australia made waves when it federally legalised medicinal cannabis in 2016, and its marijuana market has experienced significant growth since then.

A study from FreshLeaf Analytics pegs Australian medical market sales at AU$95 million in 2020, while research firm Prohibition Partners indicates that Oceania's cannabis industry is expected to be worth US$1.55 billion by 2024; medicinal cannabis is expected to account for 40 percent of the industry.

Despite that growth, the country's cannabis industry is still young. Recreational use is not yet in sight, and even medical access remains limited and highly regulated.

Keep reading... Show less

Australian Cannabis: Forecasts, Analysis and Expert Advice

Are you ready to start investing in Australia’s growing cannabis market?

Dive right in with our FREE Special Report, Australian Cannabis: Forecasts, Analysis and Expert Advice

Keep reading... Show less

How the Australian Dollar Impacts Mining Companies

The currency of Australia — the Australian dollar — is one of the most traded currencies on the planet.

Coming in at fifth globally on the foreign exchange market (FOREX), the Australian dollar is up there with the US dollar, the euro, the British pound and the Japanese yen.

Keep reading... Show less

When Will Australia Legalise Recreational Cannabis?

Recreational cannabis remains illegal in all Australia’s states and territories with the exception of the Australian Capital Territory (ACT). But could that change in the future?

So far there are no clear indicators as to when or if Australia could legalise recreational cannabis, but attitudes seem to be changing. Public support is growing, and there’s even some political acceptance.

Read on to learn more about when Australia may legalise recreational cannabis.

Keep reading... Show less

A State-by-State Guide to Cannabis in Australia

Australia made waves when it federally legalised medicinal cannabis in 2016, and its marijuana market has experienced significant growth since then.

A study from FreshLeaf Analytics pegs Australian medical market sales at AU$95 million in 2020, while research firm Prohibition Partners indicates that Oceania's cannabis industry is expected to be worth US$1.55 billion by 2024; medicinal cannabis is expected to account for 40 percent of the industry.

Despite that growth, the country's cannabis industry is still young. Recreational use is not yet in sight, and even medical access remains limited and highly regulated.

Keep reading... Show less

Australian Cannabis: Forecasts, Analysis and Expert Advice

Are you ready to start investing in Australia’s growing cannabis market?

Dive right in with our FREE Special Report, Australian Cannabis: Forecasts, Analysis and Expert Advice

Keep reading... Show less

Cannabis in the ACT: The Market a Year Post-Legalisation

It’s been just over a year since recreational cannabis was legalised in the Australian Capital Territory (ACT), home to the nation’s capital city of Canberra.

Announced on September 25, 2019, and brought into effect on January 31, 2020, the rules make it legal to possess and personally use small amounts of cannabis.

Keep reading... Show less

What Investors Should Know About Australia’s New CBD Rules

A big change is in store for the Australian cannabis market thanks to a new rule recently approved by the country’s health regulatory agency.

In December, the Therapeutic Goods Administration (TGA) confirmed it would begin allowing the sale of low-dose cannabidiol (CBD) products over the counter by a pharmacist.

Keep reading... Show less

Top News

Related News